Related Experiment Video

Updated: Oct 13, 2025

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

17.5K

Early post-septal myectomy outcomes for hypertrophic obstructive cardiomyopathy

Alexandr V Afanasyev1, Alexandr V Bogachev-Prokophiev1,2, Sergei I Zheleznev1

  • 1Heart Valves Surgery Department, Meshalkin National Medical Research Center, Novosibirsk, Russian Federation.

Asian Cardiovascular & Thoracic Annals
|November 10, 2021
PubMed

Insights

Septal myectomy for hypertrophic cardiomyopathy shows favorable early outcomes, with safety and efficacy influenced by surgeon experience. Previous alcohol septal ablation increases pacemaker needs.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Cardiovascular Research

Background:

  • Hypertrophic cardiomyopathy (HCM) is a significant cause of heart disease.
  • Septal myectomy is a key surgical intervention for obstructive HCM.
  • Evaluating early outcomes is crucial for refining surgical techniques.

Purpose of the Study:

  • To assess the early safety and efficacy of septal myectomy in HCM patients.
  • To identify factors influencing surgical outcomes and complications.
  • To compare outcomes with established clinical guidelines.

Main Methods:

  • Retrospective analysis of 583 patients undergoing septal myectomy over 9 years.
  • Data collection included patient demographics, procedural details, and early outcomes.
  • Statistical analysis to determine mortality, morbidity, and associated risk factors.

Main Results:

  • Overall early mortality was 1.9%, with variations based on concomitant procedures.
  • Complications included left ventricular wall rupture (0.7%) and ventricular septal defect (1.5%).
  • Pacemaker implantation for AV disturbances occurred in 5.0%, linked to prior alcohol septal ablation.

Conclusions:

  • Early septal myectomy outcomes align with 2020 ACC/AHA guidelines.
  • Surgeon dependency significantly impacts safety and efficacy.
  • Experience and training are vital for optimizing septal myectomy results.
Abstract

Keywords:
SAMSeptal myectomycardiachypertrophic cardiomyopathymitral regurgitation (including all etiologies)mitral systolic anterior motion

More Related Videos

Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

908
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.6K

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
54
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
64
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
93
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
70
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
42
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
102